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The prosequence of procaricain forms an a-helical domain that
prevents access to the substrate-binding cleft
Matthew R Groves, Mark AJ Taylor, Mandy Scott, Nicola J Cummings 
Richard W Pickersgill* and John A Jenkins*
Background: Cysteine proteases are involved in a variety of cellular processes
including cartilage degradation in arthritis, the progression of Alzheimer’s
disease and cancer invasion: these enzymes are therefore of immense biological
importance. Caricain is the most basic of the cysteine proteases found in the
latex of Carica papaya. It is a member of the papain superfamily and is
homologous to other plant and animal cysteine proteases. Caricain is naturally
expressed as an inactive zymogen called procaricain. The inactive form of the
protease contains an inhibitory proregion which consists of an additional 106
N-terminal amino acids; the proregion is removed upon activation.
Results: The crystal structure of procaricain has been refined to 3.2 Å
resolution; the final model consists of three non-crystallographically related
molecules. The proregion of caricain forms a separate globular domain which
binds to the C-terminal domain of mature caricain. The proregion also contains
an extended polypeptide chain which runs through the substrate-binding cleft,
in the opposite direction to that of the substrate, and connects to the
N terminus of the mature region. The mature region does not undergo any
conformational change on activation.
Conclusions: We conclude that the rate-limiting step in the in vitro activation
of procaricain is the dissociation of the prodomain, which is then followed by
proteolytic cleavage of the extended polypeptide chain of the proregion. The
prodomain provides a stable scaffold which may facilitate the folding of the
C-terminal lobe of procaricain.
Introduction
Caricain, previously known as papaya protease omega, is
the most basic protease from the latex of Carica papaya.
The mature enzyme consists of 216 amino acids (24kDa)
folded into a bilobal structure, with the N-terminal lobe
being predominantly helical and the C-terminal lobe being
predominantly b sheet [1]. The substrate-binding cleft
runs perpendicular to the active-site helix which supports
the cysteine residue of a catalytic imidazolium thiolate ion
pair. Caricain is homologous to other plant cysteine pro-
teases whose crystal structures are known: papain [2];
actinidin [3]; papaya protease IV (PPIV; now known as
glycyl endopeptidase) [4]; and mammalian cathepsin B [5].
Caricain is naturally expressed as a pre-enzyme, the short
N-terminal presequence targets the protein for secretion
and the protein remains inactive until the N-terminal 106
amino acid proregion is proteolytically removed. Activa-
tion of procaricain in vitro occurs at pH 4.0 [6] with prote-
olysis of the N-terminal part of the polypeptide chain. In
papain, this in vitro activation process leaves a ragged
N-terminal extension on the mature protease [7], which is
removed by subsequent enzymatic proteolysis. The initial
in vitro activation process has been described as an
intramolecular event [8,9], although the in vitro conditions
are likely to be very different to the conditions within
Carica papaya in vivo, where there is an abundance of dif-
ferent cysteine proteases [10]. A 30kDa species has been
observed during the activation of propapain in vitro that
may indicate that processing occurs in a step-wise fashion
[9]. Baker et al. [11] recently demonstrated that the PPIV
pro-enzyme, pro-PPIV, is catalytically active, although
crowding of the active-site cleft precludes the in vitro scis-
sion of the prosequence from the mature sequence.
The proregion of papain has been shown to inhibit cari-
cain [12] and may also act as a folding template for mature
papain, as demonstrated for other proteases and suggested
for cysteine proteases [9,13]. Homology between the pros-
equences of cysteine proteases found in the latex of Carica
papaya is very high (Fig. 1); indeed recombinantly folded
proregions of various cysteine proteases have been shown
to be effective inhibitors against a wide variety of cysteine
proteases [8,12,14]. This high sequence homology for the
proregion would suggest a conserved domain structure for
the prosequence. Thus it is likely that the prosequence
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folds as separate a domain, binding to the mature enzyme
in vitro above pH4.0. Karrer et al. [15] demonstrated the
existence of two subfamilies within the cysteine protease
family; the subfamilies differ in the size of the proregion.
The structure of procathepsin B, which belongs to the
shorter pro-region family [15], has recently been solved
[16,17]. The 62 amino acid proregion of cathepsin B has
no globular structure, the proregion cradles the two
domains of the mature enzyme with a helical structure
occluding the active site.
Here we report the structure of procaricain, which has a
substantially larger proregion than cathepsin B. In order to
crystallize the intact, non-cleaved form of procaricain an
inactive, recombinant mutant was constructed in which
the active site histidine was replaced by a glycine residue.
No proteolysis could therefore occur during refolding of
the recombinant protein or during the subsequent growth
of procaricain crystals. The free active-site cysteine is then
available as a mercury-binding site, which is useful in the
preparation of heavy metal derivatives.
Results and discussion
The structure of the prodomain
The structure of procaricain has been determined at 3.2 Å
resolution with a final R factor of 22.6% (R free 28.6%).
The proregion of procaricain folds into a distinct domain
(Figs 2,3) consisting of three helices (helix a1, 13p–29p;
helix a2, 35p–59p; helix a3, 74p–82p; where ‘p’ indicates a
residue in the proregion), a short b strand (62p–66p) and
an extended polypeptide chain that passes through the
substrate-binding cleft to the N terminus of the mature
region. Helix a2 is the core of the prodomain, with the
C-terminal turn of helix a1 packing against one side and
the N-terminal turn of helix a3 packing against the other
side. The interhelix angles are approximately 90°, the
three helices forming a ‘cross motif’. The hydrophobic core
of the prodomain consists of Leu18p, Leu21p, Phe22p,
Trp25p, Met26p, Phe43p, Phe46p and Leu50p from the
helices, together with contributions from Tyr33p, Leu67p
and Ala71p. Hydrogen bonds form between several pairs
of residues providing electrostatic interactions which
further stabilize the core of the prodomain (Table 1). Two
salt bridges are found within the prodomain, one between
helices a2 and a3 (Arg42p–Glu77p) and the other between
Arg42p and Glu38p.
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Figure 1
A sequence alignment of the proregions of
caricain, papain and PPIV (now known as
glycyl endopeptidase). Differences from the
caricain sequence are highlighted in red.
Secondary structure elements of procaricain
are indicated; a helices in purple and
b strands in yellow.
Figure 2
Ribbon representation of the secondary structure elements of
procaricain. The three helices of the prodomain (blue) pack onto the
mainly b sheet C-terminal domain of mature caricain (red). An extended
polypeptide chain of the prodomain runs through the substrate-binding
cleft between the C-terminal and N-terminal domains of mature
caricain. (This figure was produced using the program QUANTA
[Molecular Simulations Inc].)
The residues Glu38p to Asn57p (Fig. 1) are located within
the Glu-X-X-X-Arg-X-X-Ile-Phe-X-X-Asn-X-X-X-Ile-X-
X-X-Asn (ERIFNIN) motif discussed by Karrer et al. [15].
This motif is found only in the sequences of members of
the larger proregion subfamily and the presence of this
motif has been used as a basis for classification. The
residues of this motif are located on the core face of helix
a2 and are involved in a series of interactions (Fig. 4).
Residues Glu38p and Arg42p are on the N-terminal end of
helix a2 and these residues interact with Glu77p, which is
positioned on helix a3. Glu77p is conserved in the prose-
quences of papaya proteases (Fig. 1) and this interaction
stabilizes the packing of helices a2 and a3. The partial
conservation of Ile45p is a result of the packing interaction
with Tyr41p, which is also partially conserved amongst the
larger proregion family [15] (Fig. 1). More important to the
integrity of the structure is the residue Phe46p, which is a
key residue in the formation of the hydrophobic core of
the prodomain. Asn49p is involved in the salt bridge inter-
action with the mature portion of procaricain (Arg138).
Ile53p contributes to the hydrophobic core of procaricain.
Asn57p, located at the C-terminal end of helix a2, makes
hydrogen bonds to the main chain of Leu65p stabilizing
the interaction between helix a2 and the b strand of the
prodomain.
The role of Asp72p and Phe70p in the activation of papain
has been discussed by Vernet et al. [18]. Substitutions at
position 72p adversely affect the activity of papain; the
structure described here reveals that Asp72p interacts with
the buried hydroxyl of Tyr33p (Table 1). In addition, the
mutation of Phe70p→His, which causes papain to activate
at pH5.0 rather than pH4.0 [18], may be explained by the
observed position of Phe70p. In the structure of procari-
cain, Phe70p is completely buried from the solvent on the
interface between the proregion and the mature enzyme.
The Phe70p→His mutation introduces an ionizable group
in the region of the S2′ pocket (notation according to
Schechter and Berger [19]). As a result the interface
between the mature region and the proregion may become
destabilized below pH5.0, as the histidine residue becomes
protonated.
The helices pack on to each other at approximately 90°
(Fig. 2) allowing the formation of a large hydrophobic core
that extends across the S2′ pocket (Fig. 5). The tempera-
ture factors vary smoothly across the molecule, with lower
temperature factors for the hydrophobic core of the
prodomain and the C-terminal domain of the mature
enzyme (Fig. 6), indicating that the prodomain may help
to stabilize the mainly b sheet, C-terminal domain during
folding. The mature portion of procaricain is found in the
active conformation indicating that there is almost no
change in conformation on activation, even at the N termi-
nus of the mature enzyme.
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Figure 3
Stereo diagram showing the Ca trace of
procaricain. The prosequence is coloured red,
the N-terminal domain of mature caricain is
coloured in green and the C-terminal domain
is in blue. (This figure was produced using the
program O [23].)
Table 1
Hydrogen bonds and salt bridges stabilizing the prodomain.
Residue 1 Residue 2 Distance (Å)
Trp25p Nε1 Leu67p O 3.1
Lys31p Nz Asp72p Od2 3.3
Tyr33p OH Asp72p Od1 2.7
Glu38p Oε2 Arg42p Nε 3.5
Arg42p Nh1 Glu77p Oε1 3.1
Arg42p Nh1 Glu77p Oε2 3.5
Arg42p Nh2 Glu77p Oε1 2.8
Asn49p Nd2 Ala71p O 2.5
Asn49p Nd2 Leu73p O 3.1
Asn57p Od1 Leu65p N 3.1
Asn57p Nd1 Leu65p O 3.1
The notation p indicates a residue within the proregion.
A search for similar structural protein motifs [20] using the
three helices of the prodomain revealed no closely similar
arrangement but did find many matches in terms of
helices packing at 90° (for instance the 90° interhelix angle
found between some of the helices of myoglobin).
Interactions between the proregion and the mature
enzyme
Interactions between the proregion and the mature enzyme
may be divided into two categories: interactions involved in
the hydrophobic interface, between the proregion and the
C-terminal lobe of the mature protein, and interactions
involving the extended polypeptide chain of the proregion
and the substrate-binding cleft.
Firstly, we will consider the interactions at the hydropho-
bic interface. At the interface between the pro and C-ter-
minal domains one salt bridge is formed (Asp48p–Arg139),
along with three electrostatic interactions (Asn49p–Arg139,
Ser62p–Glu150 and Asn75p–Gln142). In addition, Ser62p
makes a hydrogen bond from its carbonyl oxygen to the
peptide nitrogen of Ile148. The remainder of the electro-
static interactions are main chain to side chain as detailed
in Table 2. As the resolution of the data is limited to 3.2 Å a
generous (3.5Å) cut-off has been used in the preparation of
Table 2. Hydrophobic packing between the C-terminal
domain and the prodomain is good (Table 3). Phe70p,
Ala71p, Phe78p and Tyr82p pack into the S2’ pocket
(Table 3). This last hydrophobic interface, continues
across the S2′ pocket, and produces the large hydrophobic
core that extends from the prodomain into the C-terminal
domain of caricain, although the hydroxyl oxygen of
Tyr82p, which lies in the S2′ pocket, is solvent accessible.
Secondly, we will consider the interactions between the
extended polypeptide chain of the proregion and the sub-
strate-binding cleft. The extended peptide chain (residues
82p–87p) interacts with the specificity pockets S2′–S2 (Fig.
7), with Tyr82p lying in the S2′ pocket making a hydrogen
bond to Trp181 via its carbonyl oxygen. Tyr82p makes a
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Figure 4
Structural significance of the ERIFNIN motif. (a) A representation of
the residues making up the ERIFNIN motif [15] on the core face of
helix a2. Residues comprising the ERIFNIN motif are highlighted in
red. Figure produced using the program O [23]. (b) Diagram
showing the interactions made by residues within the ERIFNIN motif
[15]. The prosequence structure is represented by green helices and
red b strands; the blue helix is a portion of the mature sequence. A
salt bridge is formed between Arg42p (helix a2) and Glu77p (helix
a3) which stabilizes the packing of helices a2 and a3; this salt
bridge is further stabilized by the presence of Glu38p. A salt bridge
is also formed between the prodomain (Asp48p and Asn49p) and
the C-terminal domain (Arg139) of procaricain. Hydrogen bonds are
formed between Asn57p (helix a2) and the main chain of Leu65p,
which is situated on the end of the b strand in the prodomain. This
interaction stabilizes the packing of helix a2 and the b strand of the
prodomain. (Figures produced using MOLSCRIPT [37] and
RASTER3D [38].)
Figure 5
The packing of residues in the region of the P2′ pocket. This pocket
provides a hydrophobic interface between the proregion and mature
caricain. The electronic density is contoured at 1s. (Figure produced
using the program O [23].)
strong interaction with the surface of the mature enzyme
by filling the S2′ pocket, with Phe70p, Phe78p, His18 and
Trp181 providing additional hydrophobic contacts.
Val83p only partially fills the S1′ pocket which would suit 
a larger, more positively charged residue (e.g. histidine)
which would make better contacts with Ser136 and
Asp158. However, Val83p is stabilized by a main-chain
hydrogen bond from its peptide nitrogen to the carbonyl
of Asn79p.
Gly84p lies between the active site cysteine, Cys25, and
the solvent, effectively preventing any proteolytic activity,
and makes a hydrogen bond to the active site cysteine
(O–Sg 2.8Å). Gly84p packs very close to Gly23 (Ca:Ca
distance 3.1Å), no other amino acid would fit in this posi-
tion without a major structural change.
Ser85p occupies the S1 pocket, making a hydrogen bond
from its carbonyl oxygen to the peptide nitrogen of Gly66.
The side-chain oxygen is exposed to the solvent.
Leu86p partially fills the S2 pocket although it would suit
a larger hydrophobic residue, such as methionine, tyrosine
or tryptophan, as the closest packing residue from this
pocket (Ala160) is more than 5.0Å from Val86p Cg.
Ile87p produces the only conformational change in the
substrate-binding cleft, packing against Tyr67. Tyr67
rotates by approximately 120° around the Ca–Cb bond,
packing on to Pro68 and Pro69. A main-chain hydrogen
bond is made to the carbonyl oxygen of Gly66.
A sequence alignment of the proregions of caricain, PPIV
and papain (Fig. 1) demonstrates that the three prose-
quences are very similar, with most of the mutations in the
proregion being at the C-terminal end, after it has passed
through the active site. The charges in the sequence
Asp-Glu-Glu-Phe-Ile-Asn-Glu-Asp (DEEFINED; residues
96p–103p) are conserved across the proteases found in the
latex of Carica papaya (Fig. 1). The main chain of the region
96p–103p is visible in the final electron-density maps, but
the side chains are poorly ordered. Glu92p is also poorly
defined in the final maps but the observed density indi-
cates that it may make hydrogen bonds to two hydroxyl
oxygens from Tyr66 and Tyr 211.
The CH3Hg+ of the methyl mercury chloride derivative is
2.9Å from the Sg of Cys25 and is over 2.6Å from the
mercury in the native coordinates [1]. It is no surprise that
the CH3Hg+ can find the room necessary to bind to the
active site cysteine as the His159→Gly mutation leaves a
large cavity in the vicinity of Cys25. The CH3Hg+ binds
within 1.2Å of the modelled position of the ring of His159.
Pro-PPIV has also shown to be active against small peptide
substrates in the absence of conditions that would force dis-
sociation of the prodomain [11]. This observation indicates
that the extended polypeptide chain on the C-terminal side
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Figure 6
Diagram indicating the temperature factors of the final procaricain
model. Regions with lower temperature factors (B < 40 Å2) are
indicated by dark blue colouring, regions with the higher temperature
factors are indicated in red. (Figure produced using rasmol [39].)
Table 2
Interactions between the proregion and the mature domain
of caricain.
Residue Atom Residue Atom Distance 
(prodomain) (mature caricain) (Å)
Asp48p Od2 Arg139 NH2 3.3
Asn49p Od1 Arg139 NH2 3.3
Ser62p Og Glu150 Oε2 3.1
O Ile148 N 3.1
Tyr63p OH Pro151 O 2.5
Trp64p N Gly146 O 2.9
O Lys145 N 3.1
O Gly146 N 3.3
Gly66p N Leu143 O 2.9
Asn68p Nd2 Tyr144 O 3.0
Gln142 O 3.1
Phe70p O Gln142 Nε2 3.1
Leu73p O Gln142 Nε2 3.2
Asn75p Nd1 Gln142 Oε1 3.2
Tyr82p O Trp181 Nε1 3.5
Val83p O His159* Nd1 3.3
Gly84p O Cys25 S 2.8
Ca Gly23 Ca 3.1
Ser85p O Gly66 N 3.5
Ile87p N Gly66 O 3.1
Gln92p Oε2 Tyr67 OH 3.4
Oε2 Tyr211 OH 3.5
Glu98p Oε2 Gln114 Oε1 3.0
Glu103p N Asn120 Nd2 3.1
*The position of the histidine residue was modelled as it is not present
in the His159→Gly mutant structure.
of Tyr82p in both procaricain and PPIV must have enough
conformational freedom to allow small molecules access to
the active site.
With mercury bound to procaricain the hydrogen bond
from Cys25 to Gly84p cannot be made due to the forma-
tion of the Cys–Hg bond. Without this hydrogen bond in
the centre of the active site, residues on the C-terminal
side of Gly84p show increased conformational freedom,
possibly accounting for the low resolution limit of isomor-
phism for this derivative. In wild type procaricain Cys25
may form an ion pair with His159, in which case the
hydrogen-bonding pattern would be different from that
seen in the His159→Gly structure.
There is no secondary structural rearrangement of the
mature enzyme upon activation, unlike that seen in the
maturation of pepsinogen to pepsin [21]. The three
helices of the proregion, which are likely to fold before the
C-terminal b sheet domain of caricain, provide a stable,
hydrophobic scaffold for the formation of the S2′ pocket.
It is unlikely that the prodomain can be cleaved intramol-
ecularly as the polypeptide chain passes through the
active site in the reverse manner to that expected for the
substrate. Binding in the reverse direction, necessary for
cleavage, would require the dissociation of the prodomain
from the mature region. Therefore, it is reasonable to
hypothesize that the in vitro activation process starts with
the breakdown of the hydrophobic interface between the
proregion and the C-terminal domain, dissociation of the
prodomain and subsequent intermolecular cleavage in the
region of residues 88p–106p. Thus the in vitro rate-deter-
mining step would be intramolecular as suggested by
Mach et al. [8] and Fox et al. [14]. The propeptide passing
through the active site inhibits the enzyme by preventing
substrate access to the catalytic apparatus, rather than
mimicking the transition state.
The 30kDa species observed in the activation of papain [9]
is possibly a shorter proregion form of propapain [15].
Cleavage of the proregion at the turns at either end of helix
a2 would yield an inactive enzyme of approximately the
right molecular mass. Cleavage at the N-terminal side of
helix a2 is more likely (Phe33–Tyr34), producing a 32kDa
species, than at the C-terminal end (Asn60–Asn61–Ser62).
The N terminus of the mature enzyme cannot bind pro-
ductively to its own active site without major structural
rearrangement; so the final cleavage of residual N-terminal
residues is likely to be intermolecular.
Comparison of procaricain with modelled pro-PPIV and
propapain
Propapain and Pro-PPIV were modelled using the PDB
coordinates (Papain:1pec [22], PPIV: 1gec [4]). The
sequences of these proteins were aligned against pro-
caricain, and then structurally aligned using the experi-
mental coordinates within the program O [23], making the
necessary sequence changes to the proregion. 
As can be seen from the sequence alignment of the prore-
gions of caricain, PPIV and papain (Fig. 1) there is a very
high sequence homology, with most of the sequence
changes being far from the proregion/mature region inter-
face and conservative in nature. In propapain the sequence
changes at 28p, 32p, 34p, 36p, 40p, 51p, 73p, 88p, 94p and
95p (Fig. 1) are such that the interaction between the
proregion and the mature region is unlikely to be affected,
as these residues make no contact with the mature region
in the procaricain structure. In the case of pro-PPIV the
changes at 28p, 32p, 34p, 51p, 60p, 88p, 90p, 91p, 92p and
94p (Fig. 1) may be treated similarly. The effect of each
mutation is summarized in Table 4.
The majority of changes are explicable in terms of muta-
tions on the surface of the mature proteins close to the posi-
tion of the propeptide chain. However, the changes at
residue 87p (caricain, isoleucine; PPIV, proline; papain,
alanine) are a consequence of the mutation in both proteins
from Pro69 to tryptophan(in papain)/serine(in PPIV). These
mutations would not allow the rotation of Tyr67 (present in
all three), found in procaricain, when the proregion is
bound. Hence, the smaller residues reduce steric hindrance
on binding of the proregion and the mature region.
In PPIV there is the substitution Gly23→Glu in the S1
pocket, but there is no compensating charge change in the
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Table 3
Hydrophobic interactions between the proregion and mature
caricain.
Residue Accessible area (Å2) Loss of 
Isolated proregion/ Procaricain accessibility in
mature caricain procaricain (Å2)
Tyr52p 146.44 57.25 89.19
Ile53p 20.49 8.39 12.10
Tyr63p 126.22 12.96 113.26
Trp64p 206.21 129.13 77.08
Leu65p 60.71 6.19 54.52
Phe70p 76.23 4.30 71.93
Ala71p 6.36 0.21 6.15
Phe78p 65.37 0.00 65.37
Tyr82p 111.07 31.00 80.07
Pro140 47.69 9.36 38.33
Leu143 90.10 0.00 90.10
Tyr144 11.55 0.05 11.50
Gly146 37.08 1.05 36.03
Gly147 35.14 2.31 32.83
Ile148 37.08 11.03 26.05
Phe149 13.10 0.44 12.66
Trp181 61.84 7.85 53.99
Trp185 21.14 0.11 21.03
This table was calculated using NACCESS [36].
proregion. The, apparently, buried charge may account for
the lower affinity of PPIV towards its proregion.
Comparison with procathepsin B
Comparisons of the recently published structures of human
[16] and rat [17] procathepsin B’s with procaricain have
shown that the proregions of enzymes within both sub-
families of cysteine protease bind to the mature enzyme
[15] in a similar manner. The main difference between the
two subfamilies being that the papain-like enzymes have
an extra 40 amino acids, which form an additional globular
domain.
The proregion of procaricain adopts a more extended con-
formation within the substrate-binding cleft than that
demonstrated in rat procathepsin B [17]. In both structures
there is no interaction between the prodomain and the
active-site histidine so it may be concluded that the muta-
tion of the active-site histidine in procaricain will have
little effect on the conformation of the proregion within
the substrate-binding cleft. In the higher resolution struc-
ture of procathepsin B [17] the mutation of the active site
cysteine to a serine residue results in a pattern of hydrogen
bonds around Gly84p that is not found in the structure of
procaricain. These extra hydrogen bonds may account for
the observed differences in conformation for the residues
within the pockets S2′–S2. In addition, procathepsin B has
a threonine residue in S1, rather than a serine, which
hydrogen bonds to the carbonyl oxygen of Ala200; the Og
of the serine in procaricain is found exposed to the solvent.
Similarly, this difference could be a result of the distorting
effect of hydrogen bonds from the active site cysteine
mutation in rat procathepsin B.
Comparison with inhibitors of papain and PPIV
The polypeptide chain of the proregion binds in the same
direction as the E64 [22] and benzoylcarbonyl-Leu-Val-
Gly-methylene inhibitors [4] and in the opposite manner
to the leupeptin inhibitor [24], which binds in the same
manner as the substrate. There is no covalent binding of
the proregion to the active site cysteine residue; the
absence of any covalent binding allows activation and
reversible inhibition of caricain by its proregion. PPIV
and caricain are very similar in terms of the structure of
their specificity pockets; with the exception of the muta-
tions Gly23→Glu and Gly65→Arg in the S1 pocket and
Ser21→Tyr in the S2 pocket. The residue at position 69
is a serine in PPIV, rather than a proline as in caricain, so
a conformational change in Tyr67 is possible.
Papain and caricain are similar in specificity pockets except
for Thr162→Ala (caricain→papain) and His18→Asn in 
the S2′ pocket, Ser136→Ala and Lys137→Ala in the S1′
pocket and Lys64→Asn in the S1 pocket. The Pro69→Trp
(caricain→papain) mutation does not allow the conforma-
tional change in Tyr67.
Papain complexed with E64
The crystal structure of papain complexed with the
inhibitor molecule E64 has been determined [22]. The
amino acid residue Pro69 in caricain allows for the rotation
of residue Tyr67. However, in papain this residue is
replaced by tryptophan with the result that the rotation of
Tyr67 is not possible. Consequently, the E64 inhibitor
must adopt a different conformation in the S1 and S2
pockets. None of the hydrogen bonds on the prime side of
the bond which is cleaved are mimicked by the proregion
of caricain. However on the non-prime side of the cleaved
bond the hydrogen bonds to Gly66 are reproduced. The
hydrogen bond to the carbonyl oxygen of Asp158 is not
mimicked as the proregion Ser85p does not bind so deep
in the S1 pocket. Conversely, Leu86p and Ile87p of the
proregion bind deeper into the S1 and S2 pockets than the
equivalent residues of E64.
Papain complexed with leupeptin and chloromethyl ketone
The crystal structures of papain complexed with leu-
peptin [24] and with chloromethyl ketone [25] have been
determined. The leupeptin inhibitor binds to papain in
the opposite direction to that of the proregion, E64 or
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Figure 7
A diagram showing the proregion as it passes through the substrate-
binding cleft. The proregion is shown in ball-and-stick representation
and caricain is depicted as a molecular surface representation; the
most negative potentials are shown in red, the most positive are in
blue. The position of Gly84p is indicated by the black arrow. The
C-terminal domain of caricain is towards the top of the picture and the
position of Asp158 is indicated. The surface is contoured at ± 12.5eV.
(Figure produced using GRASP [40].)
benzoylcarbonyl-Leu-Val-Gly-methylene, mimicking the
mode of binding of the substrate. It binds in a more
similar manner to the proregion in the S1 and S2 pockets,
with the P2 residue overlapping well with Ile87p. P1 is a
worse fit to Leu86p but binds in a more similar manner to
Leu86p than the P1 residue of E64. A better fit to the P1
of procaricain is displayed by the phenyl-like residue in
the unrefined papain–chloromethyl ketone complex
(PDB:1pad) [26] which binds in the same manner as leu-
peptin. Again the hydrogen-bonding network on the non-
prime side is retained with the exception of the hydrogen
bond to the carbonyl oxygen of Asp158.
PPIV complexed with benzoylcarbonyl-leucine-valine-
glycine-methylene 
The structure of PPIV complexed with benzoylcarbonyl-
Leu-Val-Gly-methylene [4] demonstrated the way in which
this inhibitor binds to PPIV. The largest difference in the
mode of binding, between this inhibitor and the proregion
of caricain, is the extension of this inhibitor to the S3
pocket, which is unoccupied in procaricain. The network of
hydrogen bonds on the non-prime side is retained, except
for the hydrogen bond made to the carbonyl of Asp158.
The mutation Ser21→Tyr that would pack against Tyr82p
in the S2′ pocket should provide better binding of the
proregion.
Biological implications
Cysteine proteases represent a major component of the
lysosomal proteolytic enzymes and play an important part
in protein degradation. They are involved in a variety 
of clinically important processes: allergic reactions,
Alzheimer’s disease, cartilage degradation in arthritis,
cancer invasion and metastasis, extracellular protein
degradation, osteoporosis, bone resorption, prohormone
processing and antigen processing. Cysteine proteases are
produced as inactive precursor proteins which contain an
inhibitory proregion; removal of the proregion activates
the protease. The proregions of cysteine proteases are
essential for correct folding of the mature enzymes and
are inhibitors of their respective enzymes.
A structural study of the interactions between the prore-
gion and the mature region of cysteine proteases provides
an insight into the activation process and specific inhibi-
tion of these proteins, possibly with a view to designing a
small peptide-like molecule which will specifically inhibit
the enzyme by interacting directly with the mature
protein or its precursor form.
There is no covalent binding of the proregion to the active
site cysteine; the strength of interaction between the pro-
domain and the mature enzyme is maintained by good
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Table 4
Mutations and their effects in procaricain, propapain and pro-PPIV.
Residue Procaricain Pro-PPIV Propapain Comment 
56p Thr Arg Thr Possible hydrogen bond between Arg56p and 
Ser152 in ProPPIV, Pro152 in caricain.
59p Lys Met Lys Additional hydrophobic packing against the core 
of the prodomain.
62p Ser Gly Ser No interaction with Glu150.
69p Glu Glu Val Val69p in contact with Asn18 in papain, His18 in 
PPIV and caricain.
71p Ala Ser Ala Possible hydrogen bond between Ser71p and 
Asn143 in PPIV, Leu143 in caricain and papain.
79p Asn Lys Lys In both papain and PPIV residue 137 is alanine, 
lysine in caricain.
86p Leu Leu Ile Conservative sequence change.
87p Ile Pro Ala See discussion in text.
89p Ala Asp Asn In contact with Tyr70 in caricain. 
70 is serine in papain and threonine in PPIV.
90p Thr Tyr Tyr Mutation at residue 70 (above) allows a 
larger residue.
92p Glu Asn Thr Glu92p contacts two tyrosines in caricain. 
In PPIV Asn92p makes the same contacts. 
In papain one of these tyrosines is a phenylalanine.
93p Gln Gln Thr Possible hydrogen bond between Thr93p and 
Gln73p in papain, Glu93p in caricain.
packing onto the surface of mature caricain. The binding
of the proregion in the substrate-binding cleft leaves a few
large cavities, possibly to avoid too good a fit as the pro-
domain must be removed for in vivo activation.
The extended hydrophobic core to S2′ (notation accord-
ing to Schechter and Berger [9]) may stabilize the C-ter-
minal domain of procaricain during folding. The structure
of the prodomain is predominantly a helical and these
helices pack together at frequently observed interhelical
angles. Thus it is likely that these helices would fold inde-
pendently so that they may rapidly form a scaffold for the
formation of the secondary and tertiary structure in the
vicinity of the S2′ pocket.
The initial step in the activation process would be the
dissociation of the prodomain, followed by intermolecu-
lar cleavage of the polypeptide chain. The proregion
polypeptide chain, from the active site to the N terminus
of the mature portion, is not long enough for it to bind
through the active site in the opposite manner necessary
for cleavage.
Analysis of the interactions between the prodomain and
the substrate-binding cleft of procaricain suggest muta-
tions that may increase the affinity of the proregion for
the mature enzyme, reduce the activation pH or provide
a reversible inhibitor. The sequence of residues His–
Gly–Ser–(Met/Trp/Tyr) may be more complementary to
the specificity pockets P1′–P3 and these substitutions
might result in tighter binding of the proregion to mature
caricain.
Materials and methods
Site-directed mutagenesis, expression and purification
Procaricain was expressed in E. coli [6]. The His159→Gly mutant of
procaricain was constructed to eliminate autocatalytic processing of
the protein. Substitution of the active-site histidine with glycine pro-
duced a catalytically inactive protein that was unable to independently
process itself to the mature enzyme. The substitution was introduced
by using inverse PCR. The thermal cycling conditions consisted of an
initial denaturation at 94° C for 1.5 min, followed by 25 cycles of ampli-
fication (94° C for 1 min, 55° C for 1 min and 72° C for 12 min). The
mutagenic primers were 5′-CCATGCGGTACCAAAGTAGATGGT-
GCAGTAACAGCAGTT-3′ and 5′- CCCCTCAAATATTCCCCCTTTAT-
ACAA-3′. Subsequent handling of the PCR reaction were as detailed
in Taylor et al. [27]. The mutated cDNA was expressed from the
inducible T7 promoter of pET3a in BL21(DE3) cells [6] as insoluble
inclusion body material. The inclusion bodies were solubilized and
refolded as described previously [28].
Crystallization
All crystals were produced using the hanging drop technique at 11° C.
Orthorhombic crystals were grown employing protein concentrations
of 11–17mg mL–1 in 50 mM sodium acetate buffer pH 5.0. The drops 
contained 3 ml of protein and 3 ml of reservoir solution that contained
3.0–3.4 M sodium formate, 0.1–0.2 M sodium chloride and 0.1 M
sodium acetate buffer pH 4.6–5.0 (due to the presence of sodium
formate the final pH of the hanging drops was approximately neutral).
Prism-shaped crystals appeared within one to two weeks and were
large enough for data collection within a month, reaching a maximum
length of 0.8 mm.
Data collection
Initial data collection indicated that the crystals were susceptible to
radiation damage. Subsequently all data were collected using a
cryostream (Oxford Instruments) to keep the loop mounted crystals
cooled to 100 K. Cryoprotectants consisting of the reservoir, or heavy-
metal soaking solution and 33 % v/v glycerol were used. No increase
in resolution was obtained with this technique although the lifetime of
the crystals was dramatically increased. Data were collected at the
Synchroton Radiation Service Daresbury (stations 9.5 and 9.6). A
summary of the data collected is given in Table 5. All data sets were
reduced using Denzo [29] and scaled using the CCP4 [30] suite.
Molecular replacement
Molecular replacement using AMoRe [31] with the orthorhombic data
sets gave three solutions using the mature caricain coordinates as a
search model. Using reflections in the resolution range 10–3.5Å,
three molecular replacement solutions were found with an overall R
factor of 0.485 and a correlation coefficient of 0.385. However
density for the proregion in initial maps, phased using the molecular
replacement solution with the mature caricain coordinates, was
extremely poor. Averaging the density across the three molecules in
the asymmetric unit gave no substantial improvement, as the boundary
between individual procaricain molecules and the solvent could not be
accurately defined. Some helical density for the proregion could be
seen in averaged maps but the vast majority of the proregion could not
be assigned to density.
Isomorphous replacement and density modification
Optimal soaking conditions were 1.5 mM methyl mercury chloride for
1.5 h. The soaking solution was made up of sodium acetate in place
of sodium formate to prevent precipitation; crystals were transferred
from the formate solution to the acetate solution in 0.5 M steps. Data
collected from these crystals were isomorphous with procaricain
crystals to 5 Å (Riso = 0.21 at 5.0 Å). The difference Patterson maps
were difficult to interpret but a difference Fourier map, phased on the
basis of the molecular replacement solution, gave peaks of height
6–8s within 3 Å of the molecular replacement-based position of the
active-site cysteine for each of the three molecules in the asymmetric
unit. The self-and cross-peaks in the difference Patterson maps could
then be assigned.
A map was calculated using combined phases from the molecular
replacement model and the isomorphous data to 5 Å, and phases
from the molecular replacement model alone from 5 to 3.2 Å. The
combined map showed much improved density for the proregion and
enabled the accurate definition of a solvent/protein boundary. Itera-
tive rounds of model building and mask editing with density modifica-
tion techniques enabled 90 amino acids of the 106 to be assigned to
electron density. The density modification procedure consisted of
solvent flattening, histogram matching in DM [32] and averaging
using RAVE [20].
Refinement
Once the maps were of sufficient quality such that 90 amino acids of
the proregion could be assigned to density, refinement was started
using X-PLOR [33], with 3 % of the data for R free tests, distributed
evenly in resolution shells to 3.2 Å [20]. The initial R factor for reflections
to 3.2 Å was 40.4 % (R free 41.6 %). Rigid-body refinement treating the
prodomain and the mature portion of each molecule as rigid bodies
gave a slight improvement in the R factor (38.1 %, R free 39.9 %) and
improved the non-crystallographic symmetry matrices. Positional refine-
ment initially used strict non-crystallographic symmetry to constrain 
the model. Iterative rounds of positional refinement, simulated-annealing
protocols and model building reduced the R factor to 29.8 % (R free
33.5%) for all data to 3.2 Å.
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All available data (90.6 to 3.2 Å) were used in refinement with a solvent
correction being applied to the model at the beginning of each refine-
ment step. The solvent was defined using a probe of radius 0.24 Å,
assigned a density of 0.34e/ Å3 and a temperature factor of 50 Å2
(Kostrewa, D., personal communication). The Engh and Huber [34] dic-
tionary for bond lengths and bond angles was used to restrain the
geometry of the procaricain model during refinement.
After refinement the electron density for the regions 1p–12p and
85p–100p was still very poor which, along with a high potential energy
in X-PLOR for non-crystallographic van der Waals contacts, indicated
a genuine breakdown in the non-crystallographic symmetry. Non-crys-
tallographic symmetry restraints on position and temperature factors
were then used as a basis for refinement, omitting residues 1p–12p for
which no interpretable density could be seen and unrestraining the
region 85p–100p, which is involved in lattice contacts. At this point
simulated-annealing protocols and positional refinement reduced the
R factor to 28.1 % (R free 32.5 %). Further positional and grouped tem-
perature-factor refinement using data to 3.2 Å gave a final R factor of
22.6 % (R free 28.6 %) for a model containing 310 amino acids. The
geometry of the model has been tightly restrained to ideal values, with
78.2 % of amino acid residues lying in the most favourable region 
of the Ramachandran plot and an overall G factor of 0.0. The first 11
N-terminal residues of the proregion could not be seen and have been
omitted from the final model.
The overall temperature factor on anisotropic scaling in X-PLOR is
53.7 Å2. The high temperature factors of the model are similar to those
found in the 3.2 Å structure of HIV-RT (PDB:1hmv) [35] and most
probably reflect variations from ideal non-crystallographic symmetry,
variations which cannot be modelled at this resolution. The non-crystal-
lographic positional and temperature-factor restraints cannot be
removed as the data/parameter ratio is 27079/22023 (1.23) for posi-
tional and grouped temperature factors, indicating that modelling of
any genuine non-crystallographic differences would result in overfitting
of the data. Static disorder probably also contributes to the high overall
temperature factor; the maximum resolution to which the crystals dif-
fract being 3.2 Å.
Density for the region 90p–100p remains weak indicating a highly
mobile or poorly ordered piece of chain. Data does not extend to a suf-
ficient resolution to allow refinement without imposing non-crystallo-
graphic symmetry restraints.
Accession numbers
The coordinates and structure factors of procaricain have been
deposited with the PDB; coordinate file 1PCI and related structure
factor file R1PCISF.
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